Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.42 - $1.48 $40,488 - $142,672
-96,400 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$1.06 - $2.68 $314 - $795
297 Added 0.31%
96,400 $111,000
Q4 2021

Feb 14, 2022

SELL
$2.5 - $5.19 $16,000 - $33,216
-6,400 Reduced 6.24%
96,103 $240,000
Q3 2021

Nov 10, 2021

SELL
$4.82 - $8.46 $45,308 - $79,524
-9,400 Reduced 8.4%
102,503 $525,000
Q2 2021

Jul 30, 2021

SELL
$6.81 - $9.71 $40,866 - $58,269
-6,001 Reduced 5.09%
111,903 $930,000
Q1 2021

May 06, 2021

SELL
$7.45 - $12.32 $145,990 - $241,422
-19,596 Reduced 14.25%
117,904 $1.03 Million
Q3 2020

Nov 12, 2020

SELL
$11.73 - $16.25 $34,017 - $47,125
-2,900 Reduced 2.07%
137,500 $1.64 Million
Q2 2020

Aug 13, 2020

BUY
$13.68 - $20.46 $465,120 - $695,640
34,000 Added 31.95%
140,400 $2.26 Million
Q1 2020

May 14, 2020

SELL
$14.83 - $26.72 $22,245 - $40,080
-1,500 Reduced 1.39%
106,400 $1.65 Million
Q2 2019

Aug 14, 2019

BUY
$11.43 - $15.12 $329,184 - $435,456
28,800 Added 36.41%
107,900 $1.35 Million
Q4 2018

Feb 13, 2019

BUY
$5.22 - $10.44 $2,610 - $5,220
500 Added 0.64%
79,100 $487,000
Q2 2018

Aug 13, 2018

BUY
$12.85 - $18.45 $308,400 - $442,800
24,000 Added 43.96%
78,600 $1.07 Million
Q1 2018

May 14, 2018

BUY
$12.5 - $19.75 $205,000 - $323,900
16,400 Added 42.93%
54,600 $969,000
Q4 2017

Feb 13, 2018

SELL
$11.55 - $20.1 $48,510 - $84,420
-4,200 Reduced 9.91%
38,200 $479,000
Q3 2017

Nov 13, 2017

BUY
$12.7 - $19.25 $538,480 - $816,200
42,400
42,400 $808,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.